nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—Irinotecan—colon cancer	0.143	0.178	CbGbCtD
Zafirlukast—ABCG2—Fluorouracil—colon cancer	0.137	0.17	CbGbCtD
Zafirlukast—ABCG2—Vincristine—colon cancer	0.125	0.155	CbGbCtD
Zafirlukast—CYP2C9—Capecitabine—colon cancer	0.0858	0.107	CbGbCtD
Zafirlukast—ABCG2—Methotrexate—colon cancer	0.0755	0.094	CbGbCtD
Zafirlukast—CYP2C8—Fluorouracil—colon cancer	0.0729	0.0908	CbGbCtD
Zafirlukast—CYP1A2—Fluorouracil—colon cancer	0.0564	0.0703	CbGbCtD
Zafirlukast—CYP2C9—Fluorouracil—colon cancer	0.0509	0.0633	CbGbCtD
Zafirlukast—CYP3A4—Irinotecan—colon cancer	0.0308	0.0384	CbGbCtD
Zafirlukast—CYP3A4—Vincristine—colon cancer	0.0269	0.0335	CbGbCtD
Zafirlukast—Tolvaptan—ABCB1—colon cancer	0.00321	0.768	CrCbGaD
Zafirlukast—Blister—Fluorouracil—colon cancer	0.00295	0.0182	CcSEcCtD
Zafirlukast—Numbness—Vincristine—colon cancer	0.00275	0.017	CcSEcCtD
Zafirlukast—Sensory loss—Vincristine—colon cancer	0.00263	0.0162	CcSEcCtD
Zafirlukast—Numbness—Fluorouracil—colon cancer	0.00257	0.0158	CcSEcCtD
Zafirlukast—CYSLTR1—smooth muscle tissue—colon cancer	0.00255	0.0924	CbGeAlD
Zafirlukast—Accidental injury—Irinotecan—colon cancer	0.00251	0.0155	CcSEcCtD
Zafirlukast—Sensory loss—Fluorouracil—colon cancer	0.00245	0.0151	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Irinotecan—colon cancer	0.00244	0.0151	CcSEcCtD
Zafirlukast—Raised liver function tests—Methotrexate—colon cancer	0.0024	0.0148	CcSEcCtD
Zafirlukast—Leukocytoclastic vasculitis—Methotrexate—colon cancer	0.00226	0.0139	CcSEcCtD
Zafirlukast—Neuropathy—Vincristine—colon cancer	0.00214	0.0132	CcSEcCtD
Zafirlukast—Haematemesis—Capecitabine—colon cancer	0.00214	0.0132	CcSEcCtD
Zafirlukast—Blister—Capecitabine—colon cancer	0.00206	0.0127	CcSEcCtD
Zafirlukast—Throat sore—Capecitabine—colon cancer	0.00206	0.0127	CcSEcCtD
Zafirlukast—Oropharyngeal discomfort—Capecitabine—colon cancer	0.00204	0.0126	CcSEcCtD
Zafirlukast—CYSLTR1—lymphoid tissue—colon cancer	0.00204	0.0739	CbGeAlD
Zafirlukast—Haemoptysis—Capecitabine—colon cancer	0.00201	0.0124	CcSEcCtD
Zafirlukast—Hepatotoxicity—Capecitabine—colon cancer	0.00192	0.0119	CcSEcCtD
Zafirlukast—CYSLTR1—bone marrow—colon cancer	0.00186	0.0673	CbGeAlD
Zafirlukast—Hepatic failure—Vincristine—colon cancer	0.00184	0.0114	CcSEcCtD
Zafirlukast—CYSLTR1—vagina—colon cancer	0.00178	0.0645	CbGeAlD
Zafirlukast—Injury—Irinotecan—colon cancer	0.00175	0.0108	CcSEcCtD
Zafirlukast—Swelling—Fluorouracil—colon cancer	0.00175	0.0108	CcSEcCtD
Zafirlukast—Contusion—Capecitabine—colon cancer	0.0017	0.0105	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Capecitabine—colon cancer	0.00165	0.0101	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Capecitabine—colon cancer	0.00163	0.0101	CcSEcCtD
Zafirlukast—Oropharyngeal pain—Capecitabine—colon cancer	0.00163	0.0101	CcSEcCtD
Zafirlukast—Dermatitis bullous—Fluorouracil—colon cancer	0.00162	0.00996	CcSEcCtD
Zafirlukast—Haematemesis—Methotrexate—colon cancer	0.00159	0.00982	CcSEcCtD
Zafirlukast—Influenza like illness—Capecitabine—colon cancer	0.00144	0.0089	CcSEcCtD
Zafirlukast—PTGS1—endothelium—colon cancer	0.00143	0.0519	CbGeAlD
Zafirlukast—Hepatotoxicity—Methotrexate—colon cancer	0.00143	0.00884	CcSEcCtD
Zafirlukast—Neuropathy—Capecitabine—colon cancer	0.0014	0.00861	CcSEcCtD
Zafirlukast—Neutropenia—Vincristine—colon cancer	0.00134	0.00825	CcSEcCtD
Zafirlukast—PTGS1—blood vessel—colon cancer	0.00132	0.0479	CbGeAlD
Zafirlukast—Eosinophilia—Fluorouracil—colon cancer	0.00132	0.00815	CcSEcCtD
Zafirlukast—Neutropenia—Irinotecan—colon cancer	0.0013	0.00804	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Vincristine—colon cancer	0.00125	0.00771	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Capecitabine—colon cancer	0.00123	0.00761	CcSEcCtD
Zafirlukast—Swelling—Capecitabine—colon cancer	0.00122	0.00754	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Methotrexate—colon cancer	0.00122	0.0075	CcSEcCtD
Zafirlukast—Jaundice—Irinotecan—colon cancer	0.00121	0.00747	CcSEcCtD
Zafirlukast—Hepatic failure—Capecitabine—colon cancer	0.0012	0.00741	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Fluorouracil—colon cancer	0.00117	0.00719	CcSEcCtD
Zafirlukast—CYSLTR1—lymph node—colon cancer	0.00115	0.0417	CbGeAlD
Zafirlukast—Hypoaesthesia—Vincristine—colon cancer	0.00114	0.00703	CcSEcCtD
Zafirlukast—Vasculitis—Methotrexate—colon cancer	0.00113	0.00699	CcSEcCtD
Zafirlukast—Dermatitis bullous—Capecitabine—colon cancer	0.00113	0.00696	CcSEcCtD
Zafirlukast—Haemoglobin—Irinotecan—colon cancer	0.00112	0.00691	CcSEcCtD
Zafirlukast—Sinusitis—Fluorouracil—colon cancer	0.00112	0.00689	CcSEcCtD
Zafirlukast—Haemorrhage—Irinotecan—colon cancer	0.00111	0.00688	CcSEcCtD
Zafirlukast—Agranulocytosis—Fluorouracil—colon cancer	0.00111	0.00685	CcSEcCtD
Zafirlukast—Haemoglobin—Fluorouracil—colon cancer	0.00107	0.00662	CcSEcCtD
Zafirlukast—Haemorrhage—Fluorouracil—colon cancer	0.00107	0.00659	CcSEcCtD
Zafirlukast—Hypoaesthesia—Fluorouracil—colon cancer	0.00106	0.00656	CcSEcCtD
Zafirlukast—Liver function test abnormal—Capecitabine—colon cancer	0.000996	0.00614	CcSEcCtD
Zafirlukast—Glyburide—ABCB1—colon cancer	0.000968	0.232	CrCbGaD
Zafirlukast—Back pain—Vincristine—colon cancer	0.000964	0.00595	CcSEcCtD
Zafirlukast—Back pain—Irinotecan—colon cancer	0.000939	0.00579	CcSEcCtD
Zafirlukast—Ill-defined disorder—Irinotecan—colon cancer	0.000901	0.00556	CcSEcCtD
Zafirlukast—Abdominal discomfort—Capecitabine—colon cancer	0.000894	0.00551	CcSEcCtD
Zafirlukast—Hepatic failure—Methotrexate—colon cancer	0.000894	0.00551	CcSEcCtD
Zafirlukast—Malaise—Irinotecan—colon cancer	0.000875	0.0054	CcSEcCtD
Zafirlukast—Neutropenia—Capecitabine—colon cancer	0.000872	0.00538	CcSEcCtD
Zafirlukast—Myalgia—Vincristine—colon cancer	0.000848	0.00523	CcSEcCtD
Zafirlukast—Discomfort—Irinotecan—colon cancer	0.000816	0.00504	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Capecitabine—colon cancer	0.000815	0.00503	CcSEcCtD
Zafirlukast—Oedema—Vincristine—colon cancer	0.000813	0.00502	CcSEcCtD
Zafirlukast—Jaundice—Capecitabine—colon cancer	0.00081	0.005	CcSEcCtD
Zafirlukast—Infection—Vincristine—colon cancer	0.000808	0.00499	CcSEcCtD
Zafirlukast—Thrombocytopenia—Vincristine—colon cancer	0.000796	0.00491	CcSEcCtD
Zafirlukast—Oedema—Irinotecan—colon cancer	0.000792	0.00489	CcSEcCtD
Zafirlukast—Myalgia—Fluorouracil—colon cancer	0.000791	0.00488	CcSEcCtD
Zafirlukast—Infection—Irinotecan—colon cancer	0.000787	0.00486	CcSEcCtD
Zafirlukast—Discomfort—Fluorouracil—colon cancer	0.000782	0.00482	CcSEcCtD
Zafirlukast—Agranulocytosis—Capecitabine—colon cancer	0.000776	0.00479	CcSEcCtD
Zafirlukast—Thrombocytopenia—Irinotecan—colon cancer	0.000776	0.00478	CcSEcCtD
Zafirlukast—Oedema—Fluorouracil—colon cancer	0.000759	0.00468	CcSEcCtD
Zafirlukast—Infection—Fluorouracil—colon cancer	0.000754	0.00465	CcSEcCtD
Zafirlukast—Haemoglobin—Capecitabine—colon cancer	0.00075	0.00463	CcSEcCtD
Zafirlukast—Haemorrhage—Capecitabine—colon cancer	0.000746	0.0046	CcSEcCtD
Zafirlukast—Hepatitis—Capecitabine—colon cancer	0.000746	0.0046	CcSEcCtD
Zafirlukast—Thrombocytopenia—Fluorouracil—colon cancer	0.000743	0.00458	CcSEcCtD
Zafirlukast—Hypoaesthesia—Capecitabine—colon cancer	0.000742	0.00458	CcSEcCtD
Zafirlukast—Liver function test abnormal—Methotrexate—colon cancer	0.000741	0.00457	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Vincristine—colon cancer	0.000741	0.00457	CcSEcCtD
Zafirlukast—Insomnia—Vincristine—colon cancer	0.000736	0.00454	CcSEcCtD
Zafirlukast—CYP2C8—renal system—colon cancer	0.000736	0.0267	CbGeAlD
Zafirlukast—Insomnia—Irinotecan—colon cancer	0.000716	0.00442	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Vincristine—colon cancer	0.000702	0.00433	CcSEcCtD
Zafirlukast—Fatigue—Vincristine—colon cancer	0.000701	0.00433	CcSEcCtD
Zafirlukast—Dyspepsia—Irinotecan—colon cancer	0.000697	0.0043	CcSEcCtD
Zafirlukast—Pain—Vincristine—colon cancer	0.000696	0.00429	CcSEcCtD
Zafirlukast—CYP2C19—digestive system—colon cancer	0.000691	0.0251	CbGeAlD
Zafirlukast—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000691	0.00426	CcSEcCtD
Zafirlukast—CYP1A2—renal system—colon cancer	0.000688	0.025	CbGeAlD
Zafirlukast—Eosinophilia—Methotrexate—colon cancer	0.000687	0.00424	CcSEcCtD
Zafirlukast—Insomnia—Fluorouracil—colon cancer	0.000686	0.00423	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Irinotecan—colon cancer	0.000684	0.00422	CcSEcCtD
Zafirlukast—Fatigue—Irinotecan—colon cancer	0.000683	0.00421	CcSEcCtD
Zafirlukast—Pain—Irinotecan—colon cancer	0.000677	0.00418	CcSEcCtD
Zafirlukast—Dyspepsia—Fluorouracil—colon cancer	0.000668	0.00412	CcSEcCtD
Zafirlukast—Abdominal discomfort—Methotrexate—colon cancer	0.000665	0.0041	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Vincristine—colon cancer	0.000665	0.0041	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000655	0.00404	CcSEcCtD
Zafirlukast—Feeling abnormal—Irinotecan—colon cancer	0.000653	0.00403	CcSEcCtD
Zafirlukast—Neutropenia—Methotrexate—colon cancer	0.000649	0.004	CcSEcCtD
Zafirlukast—Pain—Fluorouracil—colon cancer	0.000649	0.004	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Irinotecan—colon cancer	0.000648	0.004	CcSEcCtD
Zafirlukast—PTGS1—epithelium—colon cancer	0.000643	0.0233	CbGeAlD
Zafirlukast—Abdominal pain—Vincristine—colon cancer	0.000643	0.00397	CcSEcCtD
Zafirlukast—Body temperature increased—Vincristine—colon cancer	0.000643	0.00397	CcSEcCtD
Zafirlukast—Back pain—Capecitabine—colon cancer	0.000628	0.00388	CcSEcCtD
Zafirlukast—Abdominal pain—Irinotecan—colon cancer	0.000626	0.00386	CcSEcCtD
Zafirlukast—Body temperature increased—Irinotecan—colon cancer	0.000626	0.00386	CcSEcCtD
Zafirlukast—Feeling abnormal—Fluorouracil—colon cancer	0.000625	0.00386	CcSEcCtD
Zafirlukast—PTGS1—smooth muscle tissue—colon cancer	0.00062	0.0225	CbGeAlD
Zafirlukast—CYP2E1—renal system—colon cancer	0.000619	0.0225	CbGeAlD
Zafirlukast—CYP2C19—vagina—colon cancer	0.00061	0.0221	CbGeAlD
Zafirlukast—Ill-defined disorder—Capecitabine—colon cancer	0.000603	0.00372	CcSEcCtD
Zafirlukast—Urticaria—Fluorouracil—colon cancer	0.000603	0.00372	CcSEcCtD
Zafirlukast—Body temperature increased—Fluorouracil—colon cancer	0.0006	0.0037	CcSEcCtD
Zafirlukast—Hypersensitivity—Vincristine—colon cancer	0.000599	0.0037	CcSEcCtD
Zafirlukast—PTGS1—renal system—colon cancer	0.000597	0.0216	CbGeAlD
Zafirlukast—Malaise—Capecitabine—colon cancer	0.000586	0.00361	CcSEcCtD
Zafirlukast—Hypersensitivity—Irinotecan—colon cancer	0.000584	0.0036	CcSEcCtD
Zafirlukast—Asthenia—Vincristine—colon cancer	0.000584	0.0036	CcSEcCtD
Zafirlukast—Agranulocytosis—Methotrexate—colon cancer	0.000577	0.00356	CcSEcCtD
Zafirlukast—Asthenia—Irinotecan—colon cancer	0.000568	0.00351	CcSEcCtD
Zafirlukast—CYP1A2—digestive system—colon cancer	0.000565	0.0205	CbGeAlD
Zafirlukast—Hypersensitivity—Fluorouracil—colon cancer	0.000559	0.00345	CcSEcCtD
Zafirlukast—Haemoglobin—Methotrexate—colon cancer	0.000558	0.00344	CcSEcCtD
Zafirlukast—Diarrhoea—Vincristine—colon cancer	0.000557	0.00343	CcSEcCtD
Zafirlukast—Haemorrhage—Methotrexate—colon cancer	0.000556	0.00343	CcSEcCtD
Zafirlukast—Hepatitis—Methotrexate—colon cancer	0.000556	0.00343	CcSEcCtD
Zafirlukast—Myalgia—Capecitabine—colon cancer	0.000553	0.00341	CcSEcCtD
Zafirlukast—Arthralgia—Capecitabine—colon cancer	0.000553	0.00341	CcSEcCtD
Zafirlukast—Discomfort—Capecitabine—colon cancer	0.000546	0.00337	CcSEcCtD
Zafirlukast—Diarrhoea—Irinotecan—colon cancer	0.000542	0.00334	CcSEcCtD
Zafirlukast—ABCG2—bone marrow—colon cancer	0.000541	0.0196	CbGeAlD
Zafirlukast—Dizziness—Vincristine—colon cancer	0.000538	0.00332	CcSEcCtD
Zafirlukast—Pruritus—Fluorouracil—colon cancer	0.000537	0.00331	CcSEcCtD
Zafirlukast—CYP2C9—digestive system—colon cancer	0.000536	0.0194	CbGeAlD
Zafirlukast—CYP2C8—vagina—colon cancer	0.000533	0.0193	CbGeAlD
Zafirlukast—Oedema—Capecitabine—colon cancer	0.00053	0.00327	CcSEcCtD
Zafirlukast—Infection—Capecitabine—colon cancer	0.000527	0.00325	CcSEcCtD
Zafirlukast—Dizziness—Irinotecan—colon cancer	0.000524	0.00323	CcSEcCtD
Zafirlukast—Diarrhoea—Fluorouracil—colon cancer	0.000519	0.0032	CcSEcCtD
Zafirlukast—Thrombocytopenia—Capecitabine—colon cancer	0.000519	0.0032	CcSEcCtD
Zafirlukast—ABCG2—vagina—colon cancer	0.000518	0.0188	CbGeAlD
Zafirlukast—Vomiting—Vincristine—colon cancer	0.000517	0.00319	CcSEcCtD
Zafirlukast—CYP2C19—liver—colon cancer	0.000515	0.0187	CbGeAlD
Zafirlukast—CYP2E1—lymphoid tissue—colon cancer	0.000514	0.0186	CbGeAlD
Zafirlukast—Rash—Vincristine—colon cancer	0.000513	0.00316	CcSEcCtD
Zafirlukast—Dermatitis—Vincristine—colon cancer	0.000512	0.00316	CcSEcCtD
Zafirlukast—Headache—Vincristine—colon cancer	0.00051	0.00314	CcSEcCtD
Zafirlukast—CYP2E1—digestive system—colon cancer	0.000508	0.0184	CbGeAlD
Zafirlukast—Vomiting—Irinotecan—colon cancer	0.000504	0.00311	CcSEcCtD
Zafirlukast—Dizziness—Fluorouracil—colon cancer	0.000502	0.0031	CcSEcCtD
Zafirlukast—Rash—Irinotecan—colon cancer	0.000499	0.00308	CcSEcCtD
Zafirlukast—Dermatitis—Irinotecan—colon cancer	0.000499	0.00308	CcSEcCtD
Zafirlukast—CYP3A4—renal system—colon cancer	0.000498	0.0181	CbGeAlD
Zafirlukast—Headache—Irinotecan—colon cancer	0.000496	0.00306	CcSEcCtD
Zafirlukast—CYP2D6—renal system—colon cancer	0.00049	0.0178	CbGeAlD
Zafirlukast—PTGS1—digestive system—colon cancer	0.000489	0.0177	CbGeAlD
Zafirlukast—Nausea—Vincristine—colon cancer	0.000483	0.00298	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000483	0.00298	CcSEcCtD
Zafirlukast—Vomiting—Fluorouracil—colon cancer	0.000482	0.00298	CcSEcCtD
Zafirlukast—Insomnia—Capecitabine—colon cancer	0.00048	0.00296	CcSEcCtD
Zafirlukast—Rash—Fluorouracil—colon cancer	0.000478	0.00295	CcSEcCtD
Zafirlukast—Dermatitis—Fluorouracil—colon cancer	0.000478	0.00295	CcSEcCtD
Zafirlukast—Headache—Fluorouracil—colon cancer	0.000475	0.00293	CcSEcCtD
Zafirlukast—Nausea—Irinotecan—colon cancer	0.000471	0.0029	CcSEcCtD
Zafirlukast—Back pain—Methotrexate—colon cancer	0.000468	0.00289	CcSEcCtD
Zafirlukast—Dyspepsia—Capecitabine—colon cancer	0.000467	0.00288	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Capecitabine—colon cancer	0.000458	0.00282	CcSEcCtD
Zafirlukast—Fatigue—Capecitabine—colon cancer	0.000457	0.00282	CcSEcCtD
Zafirlukast—Pain—Capecitabine—colon cancer	0.000453	0.0028	CcSEcCtD
Zafirlukast—Nausea—Fluorouracil—colon cancer	0.000451	0.00278	CcSEcCtD
Zafirlukast—CYP2C8—liver—colon cancer	0.00045	0.0163	CbGeAlD
Zafirlukast—Ill-defined disorder—Methotrexate—colon cancer	0.000449	0.00277	CcSEcCtD
Zafirlukast—ABCG2—liver—colon cancer	0.000437	0.0158	CbGeAlD
Zafirlukast—Feeling abnormal—Capecitabine—colon cancer	0.000437	0.0027	CcSEcCtD
Zafirlukast—Malaise—Methotrexate—colon cancer	0.000436	0.00269	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Capecitabine—colon cancer	0.000434	0.00267	CcSEcCtD
Zafirlukast—PTGS1—vagina—colon cancer	0.000432	0.0157	CbGeAlD
Zafirlukast—Urticaria—Capecitabine—colon cancer	0.000421	0.0026	CcSEcCtD
Zafirlukast—CYP1A2—liver—colon cancer	0.000421	0.0153	CbGeAlD
Zafirlukast—Body temperature increased—Capecitabine—colon cancer	0.000419	0.00259	CcSEcCtD
Zafirlukast—Abdominal pain—Capecitabine—colon cancer	0.000419	0.00259	CcSEcCtD
Zafirlukast—Arthralgia—Methotrexate—colon cancer	0.000412	0.00254	CcSEcCtD
Zafirlukast—Myalgia—Methotrexate—colon cancer	0.000412	0.00254	CcSEcCtD
Zafirlukast—CYP3A4—digestive system—colon cancer	0.000409	0.0148	CbGeAlD
Zafirlukast—Discomfort—Methotrexate—colon cancer	0.000407	0.00251	CcSEcCtD
Zafirlukast—CYP2D6—digestive system—colon cancer	0.000402	0.0146	CbGeAlD
Zafirlukast—CYP2C9—liver—colon cancer	0.000399	0.0145	CbGeAlD
Zafirlukast—Infection—Methotrexate—colon cancer	0.000392	0.00242	CcSEcCtD
Zafirlukast—Hypersensitivity—Capecitabine—colon cancer	0.000391	0.00241	CcSEcCtD
Zafirlukast—Thrombocytopenia—Methotrexate—colon cancer	0.000386	0.00238	CcSEcCtD
Zafirlukast—Asthenia—Capecitabine—colon cancer	0.00038	0.00235	CcSEcCtD
Zafirlukast—CYP2E1—liver—colon cancer	0.000378	0.0137	CbGeAlD
Zafirlukast—Pruritus—Capecitabine—colon cancer	0.000375	0.00231	CcSEcCtD
Zafirlukast—Diarrhoea—Capecitabine—colon cancer	0.000363	0.00224	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00036	0.00222	CcSEcCtD
Zafirlukast—Insomnia—Methotrexate—colon cancer	0.000357	0.0022	CcSEcCtD
Zafirlukast—Dizziness—Capecitabine—colon cancer	0.000351	0.00216	CcSEcCtD
Zafirlukast—Dyspepsia—Methotrexate—colon cancer	0.000347	0.00214	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Methotrexate—colon cancer	0.000341	0.0021	CcSEcCtD
Zafirlukast—Fatigue—Methotrexate—colon cancer	0.00034	0.0021	CcSEcCtD
Zafirlukast—Pain—Methotrexate—colon cancer	0.000337	0.00208	CcSEcCtD
Zafirlukast—Vomiting—Capecitabine—colon cancer	0.000337	0.00208	CcSEcCtD
Zafirlukast—ABCG2—lymph node—colon cancer	0.000335	0.0122	CbGeAlD
Zafirlukast—Rash—Capecitabine—colon cancer	0.000334	0.00206	CcSEcCtD
Zafirlukast—Dermatitis—Capecitabine—colon cancer	0.000334	0.00206	CcSEcCtD
Zafirlukast—Headache—Capecitabine—colon cancer	0.000332	0.00205	CcSEcCtD
Zafirlukast—Feeling abnormal—Methotrexate—colon cancer	0.000325	0.00201	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Methotrexate—colon cancer	0.000323	0.00199	CcSEcCtD
Zafirlukast—Nausea—Capecitabine—colon cancer	0.000315	0.00194	CcSEcCtD
Zafirlukast—Urticaria—Methotrexate—colon cancer	0.000314	0.00193	CcSEcCtD
Zafirlukast—Body temperature increased—Methotrexate—colon cancer	0.000312	0.00192	CcSEcCtD
Zafirlukast—Abdominal pain—Methotrexate—colon cancer	0.000312	0.00192	CcSEcCtD
Zafirlukast—CYP3A4—liver—colon cancer	0.000304	0.011	CbGeAlD
Zafirlukast—CYP2D6—liver—colon cancer	0.0003	0.0109	CbGeAlD
Zafirlukast—Hypersensitivity—Methotrexate—colon cancer	0.000291	0.00179	CcSEcCtD
Zafirlukast—Asthenia—Methotrexate—colon cancer	0.000283	0.00175	CcSEcCtD
Zafirlukast—PTGS1—lymph node—colon cancer	0.000279	0.0101	CbGeAlD
Zafirlukast—Pruritus—Methotrexate—colon cancer	0.000279	0.00172	CcSEcCtD
Zafirlukast—Diarrhoea—Methotrexate—colon cancer	0.00027	0.00167	CcSEcCtD
Zafirlukast—Dizziness—Methotrexate—colon cancer	0.000261	0.00161	CcSEcCtD
Zafirlukast—Vomiting—Methotrexate—colon cancer	0.000251	0.00155	CcSEcCtD
Zafirlukast—Rash—Methotrexate—colon cancer	0.000249	0.00154	CcSEcCtD
Zafirlukast—Dermatitis—Methotrexate—colon cancer	0.000249	0.00153	CcSEcCtD
Zafirlukast—Headache—Methotrexate—colon cancer	0.000247	0.00153	CcSEcCtD
Zafirlukast—Nausea—Methotrexate—colon cancer	0.000234	0.00145	CcSEcCtD
Zafirlukast—CYP2D6—Metapathway biotransformation—CHST4—colon cancer	4.86e-05	0.0179	CbGpPWpGaD
Zafirlukast—CYP2C9—Metapathway biotransformation—CHST4—colon cancer	4.81e-05	0.0178	CbGpPWpGaD
Zafirlukast—CYSLTR2—Endothelins—SRC—colon cancer	4.78e-05	0.0177	CbGpPWpGaD
Zafirlukast—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—colon cancer	4.59e-05	0.0169	CbGpPWpGaD
Zafirlukast—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	4.55e-05	0.0168	CbGpPWpGaD
Zafirlukast—ABCG2—Fluoropyrimidine Activity—TYMS—colon cancer	4.31e-05	0.0159	CbGpPWpGaD
Zafirlukast—CYP1A2—Metapathway biotransformation—CHST4—colon cancer	4.11e-05	0.0152	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—HNF4A—colon cancer	4.04e-05	0.0149	CbGpPWpGaD
Zafirlukast—PTGS1—Overview of nanoparticle effects—PTGS2—colon cancer	3.59e-05	0.0133	CbGpPWpGaD
Zafirlukast—CYSLTR2—Endothelins—HRAS—colon cancer	3.36e-05	0.0124	CbGpPWpGaD
Zafirlukast—CYSLTR1—Endothelins—SRC—colon cancer	3.31e-05	0.0122	CbGpPWpGaD
Zafirlukast—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—colon cancer	3.2e-05	0.0118	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	3.17e-05	0.0117	CbGpPWpGaD
Zafirlukast—CYP2E1—Metapathway biotransformation—CHST5—colon cancer	3.14e-05	0.0116	CbGpPWpGaD
Zafirlukast—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	3.08e-05	0.0114	CbGpPWpGaD
Zafirlukast—PTGS1—Eicosanoid Synthesis—PTGS2—colon cancer	2.98e-05	0.011	CbGpPWpGaD
Zafirlukast—CYSLTR2—Endothelins—AKT1—colon cancer	2.97e-05	0.011	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—DLC1—colon cancer	2.78e-05	0.0103	CbGpPWpGaD
Zafirlukast—CYP2C8—Metapathway biotransformation—CHST5—colon cancer	2.72e-05	0.01	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—LGR5—colon cancer	2.62e-05	0.00966	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—ABCB1—colon cancer	2.52e-05	0.00932	CbGpPWpGaD
Zafirlukast—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	2.49e-05	0.00921	CbGpPWpGaD
Zafirlukast—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—colon cancer	2.49e-05	0.0092	CbGpPWpGaD
Zafirlukast—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	2.49e-05	0.00918	CbGpPWpGaD
Zafirlukast—CYP2C19—Metapathway biotransformation—CHST5—colon cancer	2.42e-05	0.00895	CbGpPWpGaD
Zafirlukast—CYSLTR1—Endothelins—HRAS—colon cancer	2.33e-05	0.00861	CbGpPWpGaD
Zafirlukast—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	2.27e-05	0.0084	CbGpPWpGaD
Zafirlukast—CYP2D6—Metapathway biotransformation—CHST5—colon cancer	2.23e-05	0.00823	CbGpPWpGaD
Zafirlukast—CYP2C9—Metapathway biotransformation—CHST5—colon cancer	2.21e-05	0.00816	CbGpPWpGaD
Zafirlukast—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	2.17e-05	0.008	CbGpPWpGaD
Zafirlukast—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	2.14e-05	0.00791	CbGpPWpGaD
Zafirlukast—CYP3A4—Irinotecan Pathway—APC—colon cancer	2.09e-05	0.00773	CbGpPWpGaD
Zafirlukast—CYSLTR1—Endothelins—AKT1—colon cancer	2.06e-05	0.0076	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-2-alpha transcription factor network—EP300—colon cancer	1.95e-05	0.00721	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—DLC1—colon cancer	1.93e-05	0.00712	CbGpPWpGaD
Zafirlukast—CYP1A2—Metapathway biotransformation—CHST5—colon cancer	1.89e-05	0.00697	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—AXIN2—colon cancer	1.88e-05	0.00694	CbGpPWpGaD
Zafirlukast—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	1.85e-05	0.00684	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-2-alpha transcription factor network—VEGFA—colon cancer	1.85e-05	0.00683	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—LGR5—colon cancer	1.81e-05	0.0067	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—colon cancer	1.72e-05	0.00636	CbGpPWpGaD
Zafirlukast—PTGS1—Arachidonic acid metabolism—PTGS2—colon cancer	1.66e-05	0.00612	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—colon cancer	1.57e-05	0.00579	CbGpPWpGaD
Zafirlukast—CYSLTR2—G alpha (q) signalling events—PIK3CA—colon cancer	1.52e-05	0.00562	CbGpPWpGaD
Zafirlukast—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	1.51e-05	0.00556	CbGpPWpGaD
Zafirlukast—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	1.5e-05	0.00554	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—colon cancer	1.48e-05	0.00547	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	1.46e-05	0.00538	CbGpPWpGaD
Zafirlukast—ABCG2—Fluoropyrimidine Activity—TP53—colon cancer	1.43e-05	0.00528	CbGpPWpGaD
Zafirlukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	1.43e-05	0.00528	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	1.38e-05	0.00508	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—colon cancer	1.36e-05	0.00503	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AXIN2—colon cancer	1.3e-05	0.00481	CbGpPWpGaD
Zafirlukast—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	1.29e-05	0.00476	CbGpPWpGaD
Zafirlukast—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	1.27e-05	0.00469	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—colon cancer	1.26e-05	0.00465	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CA7—colon cancer	1.25e-05	0.00462	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CA7—colon cancer	1.2e-05	0.00444	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—colon cancer	1.19e-05	0.00441	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—EP300—colon cancer	1.15e-05	0.00424	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—colon cancer	1.09e-05	0.00402	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—VEGFA—colon cancer	1.09e-05	0.00402	CbGpPWpGaD
Zafirlukast—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	1.07e-05	0.00395	CbGpPWpGaD
Zafirlukast—CYSLTR1—G alpha (q) signalling events—PIK3CA—colon cancer	1.06e-05	0.0039	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—PTGS2—colon cancer	1.05e-05	0.00389	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—colon cancer	1.03e-05	0.00379	CbGpPWpGaD
Zafirlukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	9.94e-06	0.00367	CbGpPWpGaD
Zafirlukast—CYP2C19—Arachidonic acid metabolism—PTGS2—colon cancer	9.55e-06	0.00353	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—colon cancer	9.44e-06	0.00349	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CA7—colon cancer	8.99e-06	0.00332	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—colon cancer	8.73e-06	0.00323	CbGpPWpGaD
Zafirlukast—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	8.71e-06	0.00322	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	7.95e-06	0.00294	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CA7—colon cancer	7.77e-06	0.00287	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CHST5—colon cancer	7.59e-06	0.0028	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ODC1—colon cancer	7.59e-06	0.0028	CbGpPWpGaD
Zafirlukast—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	7.44e-06	0.00275	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ODC1—colon cancer	7.29e-06	0.00269	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CHST5—colon cancer	7.29e-06	0.00269	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	6.95e-06	0.00257	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	6.94e-06	0.00256	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CA7—colon cancer	6.94e-06	0.00256	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	6.62e-06	0.00244	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	6.62e-06	0.00244	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	6.43e-06	0.00238	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	6.43e-06	0.00238	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CA7—colon cancer	6.38e-06	0.00236	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CA7—colon cancer	6.33e-06	0.00234	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	6.27e-06	0.00231	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	6.19e-06	0.00229	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	5.77e-06	0.00213	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	5.75e-06	0.00212	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	5.64e-06	0.00208	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	5.64e-06	0.00208	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CHST5—colon cancer	5.45e-06	0.00201	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ODC1—colon cancer	5.45e-06	0.00201	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—FGFR3—colon cancer	5.43e-06	0.002	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CA7—colon cancer	5.41e-06	0.002	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	5.33e-06	0.00197	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—APC—colon cancer	4.98e-06	0.00184	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—NRAS—colon cancer	4.98e-06	0.00184	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CHST5—colon cancer	4.71e-06	0.00174	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ODC1—colon cancer	4.71e-06	0.00174	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—BRAF—colon cancer	4.69e-06	0.00173	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—EGFR—colon cancer	4.54e-06	0.00168	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	4.53e-06	0.00167	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—PIK3CA—colon cancer	4.34e-06	0.0016	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—KRAS—colon cancer	4.29e-06	0.00158	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	4.28e-06	0.00158	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CHST5—colon cancer	4.2e-06	0.00155	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ODC1—colon cancer	4.2e-06	0.00155	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CA7—colon cancer	4.17e-06	0.00154	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—PIK3CA—colon cancer	3.94e-06	0.00146	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ODC1—colon cancer	3.87e-06	0.00143	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CHST5—colon cancer	3.87e-06	0.00143	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ODC1—colon cancer	3.83e-06	0.00142	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CHST5—colon cancer	3.83e-06	0.00142	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—FGFR3—colon cancer	3.76e-06	0.00139	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—HRAS—colon cancer	3.65e-06	0.00135	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—AKT1—colon cancer	3.55e-06	0.00131	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CASP3—colon cancer	3.51e-06	0.0013	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—APC—colon cancer	3.46e-06	0.00128	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—NRAS—colon cancer	3.46e-06	0.00128	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCND1—colon cancer	3.42e-06	0.00126	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CTNNB1—colon cancer	3.39e-06	0.00125	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CDKN1A—colon cancer	3.31e-06	0.00122	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ODC1—colon cancer	3.27e-06	0.00121	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CHST5—colon cancer	3.27e-06	0.00121	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—BRAF—colon cancer	3.25e-06	0.0012	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—AKT1—colon cancer	3.22e-06	0.00119	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—EGFR—colon cancer	3.15e-06	0.00116	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—EP300—colon cancer	3.15e-06	0.00116	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—SRC—colon cancer	3.06e-06	0.00113	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.01e-06	0.00111	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—PIK3CA—colon cancer	3.01e-06	0.00111	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—VEGFA—colon cancer	2.98e-06	0.0011	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—KRAS—colon cancer	2.97e-06	0.0011	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NRAS—colon cancer	2.94e-06	0.00109	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MYC—colon cancer	2.74e-06	0.00101	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TGFB1—colon cancer	2.74e-06	0.00101	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—PIK3CA—colon cancer	2.73e-06	0.00101	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—EGFR—colon cancer	2.68e-06	0.000991	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—KRAS—colon cancer	2.53e-06	0.000936	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HRAS—colon cancer	2.53e-06	0.000933	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CHST5—colon cancer	2.53e-06	0.000933	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ODC1—colon cancer	2.53e-06	0.000933	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—AKT1—colon cancer	2.46e-06	0.000908	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CASP3—colon cancer	2.44e-06	0.000899	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCND1—colon cancer	2.37e-06	0.000875	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.37e-06	0.000874	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CTNNB1—colon cancer	2.35e-06	0.000867	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PIK3CA—colon cancer	2.33e-06	0.00086	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CDKN1A—colon cancer	2.29e-06	0.000847	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TP53—colon cancer	2.25e-06	0.000832	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—AKT1—colon cancer	2.23e-06	0.000824	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—EP300—colon cancer	2.18e-06	0.000806	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HRAS—colon cancer	2.15e-06	0.000795	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SRC—colon cancer	2.12e-06	0.000783	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—VEGFA—colon cancer	2.07e-06	0.000763	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NRAS—colon cancer	2.04e-06	0.000754	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ABCB1—colon cancer	2.01e-06	0.00074	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—TYMS—colon cancer	1.97e-06	0.000727	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.97e-06	0.000727	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.94e-06	0.000718	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ABCB1—colon cancer	1.93e-06	0.000711	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—AKT1—colon cancer	1.9e-06	0.000702	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MYC—colon cancer	1.9e-06	0.000702	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TGFB1—colon cancer	1.9e-06	0.0007	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—TYMS—colon cancer	1.89e-06	0.000699	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—EGFR—colon cancer	1.86e-06	0.000687	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—KRAS—colon cancer	1.76e-06	0.000649	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.74e-06	0.000641	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PIK3CA—colon cancer	1.61e-06	0.000596	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.58e-06	0.000584	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TP53—colon cancer	1.56e-06	0.000577	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.53e-06	0.000565	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HRAS—colon cancer	1.49e-06	0.000551	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.46e-06	0.000538	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ABCB1—colon cancer	1.44e-06	0.000532	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—TYMS—colon cancer	1.41e-06	0.000522	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PPARG—colon cancer	1.4e-06	0.000515	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.36e-06	0.000504	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.35e-06	0.000499	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PPARG—colon cancer	1.34e-06	0.000495	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AKT1—colon cancer	1.32e-06	0.000487	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.27e-06	0.00047	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.24e-06	0.00046	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ABCB1—colon cancer	1.24e-06	0.000459	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—TYMS—colon cancer	1.22e-06	0.000451	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.14e-06	0.000419	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ABCB1—colon cancer	1.11e-06	0.00041	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTGS2—colon cancer	1.1e-06	0.000405	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TYMS—colon cancer	1.09e-06	0.000403	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.06e-06	0.000393	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTGS2—colon cancer	1.05e-06	0.000389	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.04e-06	0.000382	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ABCB1—colon cancer	1.02e-06	0.000377	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ABCB1—colon cancer	1.01e-06	0.000374	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TYMS—colon cancer	1e-06	0.00037	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PPARG—colon cancer	1e-06	0.00037	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TYMS—colon cancer	9.95e-07	0.000367	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	9.41e-07	0.000347	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—EP300—colon cancer	9.13e-07	0.000337	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.85e-07	0.000327	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—EP300—colon cancer	8.77e-07	0.000324	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPARG—colon cancer	8.66e-07	0.00032	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ABCB1—colon cancer	8.65e-07	0.00032	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TYMS—colon cancer	8.5e-07	0.000314	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.4e-07	0.00031	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS2—colon cancer	7.88e-07	0.000291	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPARG—colon cancer	7.73e-07	0.000285	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.66e-07	0.000283	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPARG—colon cancer	7.11e-07	0.000262	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPARG—colon cancer	7.05e-07	0.00026	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS2—colon cancer	6.81e-07	0.000251	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CA—colon cancer	6.75e-07	0.000249	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ABCB1—colon cancer	6.68e-07	0.000247	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TYMS—colon cancer	6.56e-07	0.000242	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—EP300—colon cancer	6.55e-07	0.000242	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.54e-07	0.000242	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CA—colon cancer	6.49e-07	0.00024	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS2—colon cancer	6.08e-07	0.000224	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPARG—colon cancer	6.02e-07	0.000222	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—EP300—colon cancer	5.66e-07	0.000209	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS2—colon cancer	5.59e-07	0.000206	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS2—colon cancer	5.54e-07	0.000205	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKT1—colon cancer	5.52e-07	0.000204	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKT1—colon cancer	5.3e-07	0.000196	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—EP300—colon cancer	5.06e-07	0.000187	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CA—colon cancer	4.85e-07	0.000179	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS2—colon cancer	4.74e-07	0.000175	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—EP300—colon cancer	4.65e-07	0.000172	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPARG—colon cancer	4.65e-07	0.000172	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—EP300—colon cancer	4.61e-07	0.00017	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CA—colon cancer	4.19e-07	0.000155	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKT1—colon cancer	3.96e-07	0.000146	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—EP300—colon cancer	3.94e-07	0.000145	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CA—colon cancer	3.74e-07	0.000138	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS2—colon cancer	3.66e-07	0.000135	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CA—colon cancer	3.44e-07	0.000127	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKT1—colon cancer	3.42e-07	0.000126	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CA—colon cancer	3.41e-07	0.000126	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKT1—colon cancer	3.06e-07	0.000113	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—EP300—colon cancer	3.04e-07	0.000112	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CA—colon cancer	2.91e-07	0.000108	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKT1—colon cancer	2.81e-07	0.000104	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKT1—colon cancer	2.79e-07	0.000103	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKT1—colon cancer	2.38e-07	8.79e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CA—colon cancer	2.25e-07	8.3e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKT1—colon cancer	1.84e-07	6.78e-05	CbGpPWpGaD
